DT-hepatitis A-hepatitis B-influenza vaccine - Berna Biotech
Latest Information Update: 12 Oct 2006
At a glance
- Originator Berna Biotech
- Class Bacterial vaccines; Hepatitis A vaccines; Hepatitis B vaccines; Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diphtheria; Hepatitis A; Hepatitis B; Influenza virus infections; Tetanus
Most Recent Events
- 12 Oct 2006 Discontinued - Phase-I for Diphtheria in Switzerland (unspecified route)
- 12 Oct 2006 Discontinued - Phase-I for Hepatitis A in Switzerland (unspecified route)
- 12 Oct 2006 Discontinued - Phase-I for Hepatitis B in Switzerland (unspecified route)